Author:
Christov Konstantin,Ikui Amy,Shilkaitis Anne,Green Albert,Yao Ruisheng,You Ming,Grubbs Clinton,Steele Vernon,Lubet Ronald,Weinstein I. Bernard
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Osborne CK: Tamoxifen in the treatment of breast cancer. N Engl J Med 339: 1609-1618, 1998
2. Fisher B, Digman J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, Smith R, Begovic M, Dimitrov NV, Margolese RJ, Kardinal CG, Kavanah MT, Fahrenbacher L, Oishi RH: Tamoxifen in treatment of intraductal breast cancer. National Surgical Ajuvant Breast and Bowel Project B-24 randomized control trial. Lancet 353: 1993-2000, 1999
3. Fisher B, Costantino JP, Wicckerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidox A, Dimitrov N, Atkins J, Daley M, Wieand S, Tan-Chiu E, Ford L, Wolmark N: Tamoxifen for prevention of breast cancer. Report of the National Surgical Adjuvant Breast and Bowel Project, P-1 study. J Natl Cancer Inst 90: 1371-1388, 1998
4. Jordan VG, Morrow M: Tamoxifen, reloxifene, and the prevention of breast cancer. Endocr Rev 20(3): 253-278, 1999
5. Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL: Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol 9(5): 359-364, 2002
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献